Healthcare -
Biotechnology - NASDAQ - US
$ 5.06
6.75 %
$ 287 M
Market Cap
-5.95
P/E
Price Target
Average
272.20%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
26.53%
Net Income
Estimate
--8.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Design Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for DSGN of $18.8 , with forecasts ranging from
a
low of
$7 to a high of $42 .
DSGN Lowest Price Target
Wall Street Target
7 USD
38.34%
DSGN Average Price Target
Wall Street Target
18.8 USD
272.20%
DSGN Highest Price Target
Wall Street Target
42 USD
730.04%
REVENUE FORECAST
Revenue Forecast Chart DSGN
EBIT FORECAST
EBIT Forecast Chart DSGN
NET INCOME FORECAST
Net Income Chart DSGN